Interproximal reduction of teeth: differences in perspective between orthodontists and dentists.

Objective: To determine if interproximal reduction of teeth (IPR) is perceived differently by orthodontists and general dentists.

Materials And Methods: A Web-based survey containing statements about IPR was developed and randomly distributed to orthodontists and general dentists.

Results: The majority of orthodontists and general dentists strongly agreed that IPR is a minimally invasive procedure that poses little risk for the development of interproximal decay.

Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.

Bisphosphonates (BPs) are medications used commonly to treat primary and metastatic bone cancer, as well as osteoporosis. Although BPs improve bone mineral density, reduce fracture risk, and reduce hypercalcemia of malignancy, some patients develop BP-related osteonecrosis of the jaws (BRONJ). This devastating complication is defined as clinically exposed bone in the maxillofacial region for more than 8 weeks.